Semaglutide day 1 side effects: what the evidence actually shows

Nausea is the most frequently reported early symptom, but it is typically mild and transient at the starting dose.
Serious reactions on day one are uncommon; the MHRA has highlighted acute pancreatitis as a known but infrequent risk requiring urgent attention if severe stomach pain develops.
You can report any suspected side effect (including reactions from day one) to the MHRA's Yellow Card scheme.
If you are unsure whether a symptom is normal, contact your prescriber rather than stopping treatment without guidance.

On the first day of semaglutide, most people notice little or nothing at all. The side-effect profile of semaglutide is well-documented in clinical trials: the most common effects are gastrointestinal, mild in the majority of cases, and tend to build gradually over the first few weeks rather than arriving immediately on day one. That said, everyone's system responds differently, and knowing what is normal — and what warrants a call to your prescriber — makes the first injection a lot less daunting. These are prescription-only medicines; a clinician reviews your suitability before any treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The first 24 hours on semaglutide: what clinical evidence and prescriber experience tell us

What the trial data says about early tolerability

The STEP 1 trial, published in the New England Journal of Medicine, enrolled 1,961 adults and tracked semaglutide 2.4mg over 68 weeks. The trial was designed to escalate the dose slowly precisely because the research team anticipated GI effects, participants began at 0.25mg and moved up every four weeks. That graduated approach is the reason the starting dose is not the treatment dose: its job is to let the body adjust before the dose climbs.

What this means on day one is that most people are injecting the lowest possible dose. Clinical-trial data show that GI symptoms are most likely to emerge, or worsen, after each dose increase rather than on day one of the lowest rung. The NHS medicines page for semaglutide confirms nausea, vomiting, diarrhoea, constipation and indigestion as common effects, and notes these often settle as the body adapts.

Individual variation is real. A minority of people do feel nauseous within hours of the first injection. Eating a light meal before injecting, staying hydrated, and avoiding rich or fatty food on day one are practical steps our prescribers frequently discuss with patients at the start of treatment. The evidence base supports a slow-and-steady start; the first 24 hours are rarely the hardest part.

Symptoms that are common on day one versus those that are not

A question our prescribers hear most weeks is: "I felt queasy this morning, is that normal?" The honest answer is yes, for most people, mild nausea on the day of or the day after the first injection sits within the expected range. What is less typical at the lowest starting dose are sustained vomiting, significant dizziness that affects your ability to stand, or pain beyond ordinary indigestion.

Common day-one experiences documented in trials and clinical practice include: low-grade nausea, a reduced appetite from that first meal onwards, occasional loose stools, and a mild headache, often related to drinking less than usual if appetite has dropped. Fatigue is also reported. If you want a detailed breakdown of what to expect from Wegovy on day one, including how these effects typically present and when they tend to peak, that guide covers each symptom in full. Most of these settle within a day or two and tend to return briefly after each subsequent dose increase.

Injection-site reactions (redness, mild itching, a small raised area of skin) can appear within hours and usually resolve quickly. Rotating the injection site across the abdomen, thigh and upper arm helps. For a fuller picture of how these effects typically evolve across the first weeks, the Wegovy side effects guide covers the longer arc in more detail.

When to get medical help, symptoms that go beyond the expected

Some reactions require prompt attention regardless of how early in treatment they occur. Severe, persistent stomach pain that radiates towards the back, with or without vomiting, can be a sign of acute pancreatitis. In January 2026 the MHRA issued a Drug Safety Update flagging pancreatitis as a known but infrequent risk with GLP-1 medicines; the MHRA Drug Safety Update advises seeking urgent medical help for this symptom pattern. Do not wait to see if it resolves on its own.

Other symptoms that warrant contacting a healthcare professional promptly include: signs of an allergic reaction such as swelling of the face, lips or throat, difficulty breathing, or a widespread rash; severe or persistent vomiting that makes it impossible to keep fluids down (dehydration can develop quickly and affect the kidneys); and any sudden changes in vision. These are not typical day-one experiences, but they can happen, and knowing them in advance means you will act quickly if they do.

For anything you are uncertain about, your prescriber is the right first call, not a search engine. You can also report any suspected side effect, including reactions that appeared from the very first day, via the MHRA Yellow Card scheme. If you are considering treatment and want to talk through what to expect, our prescribers cover this as part of the free consultation available through our treatment page.

Practical steps to make day one easier

A handful of evidence-informed habits can reduce the chance that the first injection is uncomfortable. Eat before you inject, a small, low-fat meal rather than going in on an empty stomach. Time the injection for a point in the day when you can rest if needed; many people find a weekend morning works well for the first dose. Drink water steadily through the day; nausea from semaglutide often worsens with dehydration.

Avoid alcohol on injection day, particularly early on. Keep the first day's meals light and plain: the stomach is adjusting to a medicine that deliberately slows gastric emptying, and a heavy meal will make that adjustment more noticeable. If nausea does arrive, cold or room-temperature food is often better tolerated than hot dishes. Our guide to Wegovy day two side effects explains how symptoms commonly shift overnight and what to watch for as you move into the second day.

The practical guide to managing Wegovy side effects goes deeper on each of these strategies, including what to do when symptoms persist beyond the first few days. For anyone researching the broader Wegovy treatment before starting, that page covers the full picture from dose one to maintenance. Aftercare from our clinical team is available seven days a week, the contact page has the details.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions